Hongchang International Co., Ltd

HCIL ·Healthcare, Medical Devices
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2016 FY2015
Revenue $2.9M $2.7M $79.0K $96.5K $222.7K $163.7K $188.2K $3.2M
Cost of Revenue $2.7M $2.6M $27.4K $30.3K $118.5K $83.6K $70.0K $2.8M
Gross Profit $181.6K $69.4K $51.6K $66.2K $104.2K $80.1K $118.3K $385.6K
Gross Margin 6.3% 2.6% 65.3% 68.6% 46.8% 48.9% 62.8% 12.1%
Operating Expenses
Research & Development — — — — — — $54.2K $214.9K
SG&A Expense $560.6K $538.9K $240.0K — — — $319.0K $1.6M
Operating Income $-383.3K $-469.6K $-240.0K $-162.8K $-278.8K $-538.1K $-287.9K $-1.6M
Operating Margin -13.4% -17.5% -304.0% -168.8% -125.2% -328.8% -153.0% -50.2%
Interest Expense — — — — — — $1.0K $1.2K
Pretax Income $-494.7K $-444.7K $-240.0K $-163.0K $-753.1K $-540.0K — —
Income Tax Expense $-22.3K $-65.9K — — — — — —
Net Income $-472.4K $-378.8K $-240.0K $-163.0K $-548.4K $-488.4K $-158.5K $-3.5M
Net Margin -16.5% -14.2% -304.0% -169.0% -246.2% -298.4% -84.2% -111.5%
EPS (Basic) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $-0.01
EPS (Diluted) $0.00 $0.00 $0.00 $0.00 — $0.00 $0.00 $-0.01
Shares Outstanding (Basic) 518.8M 450.2M 431.7M 7.23B 7.23B 7.78B 696.0M 696.0M
Shares Outstanding (Diluted) 518.8M 450.2M 431.7M 7.23B 7.23B 7.78B 696.0M 696.0M
Dividends Per Share — — — — — — — —
← Newer Page 1 of 2 Older →